gbca2025: FDA GBCA dataset with 1328 adverse events

In pvEBayes: Empirical Bayes Methods for Pharmacovigilance

FDA GBCA dataset with 1328 adverse events

Description

An adverse event-drug count dataset (contingency table) obtained from the FDA FAERS database for the quarters 2021Q1 - 2024Q4.

Usage

gbca2025

Format

An object of class matrix (inherits from array) with 1328 rows and 8 columns.

Details

Data are stored in the form of a contingency table, with drugs listed across the columns and the 1328 AEs presented across the rows. Each cell in the contingency table represents the total report counts associated with that (AE, drug) pair and detected in the FDA FAERS database during 2021Q1 - 2024Q4.

The dataset catalogs 7 Gadolinium-Based Contrast Agents (GBCAs) (across columns):

Gadobenate, Gadobutrol, Gadodiamide, Gadopentetate, Gadoterate, Gadoteridol, Gadoxetate

The 1328 adverse events presented across the rows are AEs that contain at least one report for the 7 GBCA drugs during 2021Q1 - 2024Q4.

This dataset is an updated version of gbca from the pvLRT package which collects the same scope of AEs for 7 gbca drugs for quarters 2014Q3 - 2020Q4.

Source

https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html

pvEBayes documentation built on Aug. 8, 2025, 6:13 p.m.